Clinical trial
SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment…
NCT00071279 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00071279 |
|---|---|
| Title | SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis |
| Official title | The Van Gogh-extension Trial, a Multicenter, International, Randomized, Double-blind, Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous SR34006 With Placebo in the Long-term Prevention of Symptomatic Venous Thromboembolism in Patients With Symptomatic Pulmonary Embolism or… |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Embolism, Deep Vein Thrombosis |
| Intervention type | Drug |
| Interventions | SR34006 (idraparinux sodium) Injection |
| Enrollment | 1,215 |
| Start date | Nov 1, 2003 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Oct 20, 2003 |
| Last update posted | Apr 6, 2011 |
| Countries | Australia, Austria, Belgium, Brazil, Canada, Czechia, Denmark, Finland, France, Germany, Italy, Netherlands and 8 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: